FREMONT, Calif., Aug. 4, 2014 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today that it will host a conference call to discuss its financial results for the quarter ended June 30, 2014. The call will be held on Thursday, August 7, 2014 at 5:00 pm ET and will be hosted by Ivan Trifunovich, President and CEO of WaferGen Bio-systems.
Participants may listen to the live broadcast by calling (877) 407-3982 for domestic participants and (201) 493-6780 for international participants.
About WaferGen Bio-systems, Inc.
WaferGen Bio-systems, Inc. is a life science company that offers innovative genomic solutions for clinical testing and research. The SmartChip MyDesign Real-Time PCR System is a high-throughput genetic analysis platform for profiling and validating molecular biomarkers via microRNA and mRNA gene expression profiling, as well as single nucleotide polymorphism (SNP) genotyping. The SmartChip TE System is a novel product offering for target enrichment geared towards clinical Next-Gen sequencing (NGS). The Company now also offers the Apollo 324 product line used in library preparation for NGS. These three complementary technologies offer a powerful set of tools enabling more accurate, faster and cheaper genetic analysis based on Next-Gen Sequencing and Real-Time PCR.
For additional information, please see http://www.wafergen.com
Investor Contact:
Kirin Smith
ProActive Capital
646-863-6519
ksmith@proactivecapital.com
Bob Yedid
ICR, Inc.
646-277-1250
bob.yedid@icrinc.com
SOURCE WaferGen Bio-systems, Inc.
